This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Connor, R I Articles by Ho, D D Search for Related Content PubMed PubMed Citation Articles by Connor, R I Articles by Ho, D D

 Previous Article  |  Next Article 

J Virol. 1994 July; 68(7): 4400-4408

Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.

Aaron Diamond AIDS Research Center, New York University School of Medicine, New York 10016.

ABSTRACT

We examined the replicative properties of a series of sequential isolates and biological clones of human immunodeficiency virus type 1 (HIV-1) obtained from an individual who progressed from seroconversion to AIDS in approximately 5 years. HIV-1 isolated soon after seroconversion replicated slowly and to low levels in cultures of peripheral blood mononuclear cells; however, subsequent isolates obtained during asymptomatic infection showed a marked increase in replication kinetics. This was examined in more detail by using a panel of 35 biological clones of HIV-1 generated from sequential patient peripheral blood mononuclear cell samples. Each clone was evaluated for replication in primary macrophages and CD4+ T lymphocytes and for the ability to induce syncytium formation in MT-2 cell cultures. Consistent with earlier observations, we found that all of the clones isolated just after seroconversion were slowly replicating and non-syncytium inducing (NSI). However, NSI variants with increased replication kinetics in macrophages were identified soon thereafter. These variants preceded the appearance of NSI and syncytium-inducing variants, with rapid replication in both macrophages and CD4+ T lymphocytes. To determine whether changes in the rate of replication could be traced to the early stages of the virus life cycle, PCR assays were used to evaluate entry and reverse transcription of selected biological clones in macrophages and CD4+ T lymphocytes. We found there was no inherent block to entry or reverse transcription for the slowly replicating variants; however, this does not preclude the possibility that small differences in the rate of entry may account for larger differences in the replication kinetics over many cycles. Overall, our results demonstrate that rapidly replicating variants of HIV-1 emerge during the asymptomatic period in a patient who subsequently progressed clinically, suggesting that these variants may play an important role in HIV-1 pathogenesis.

This article has been cited by other articles:

• Peters, P. J., Sullivan, W. M., Duenas-Decamp, M. J., Bhattacharya, J., Ankghuambom, C., Brown, R., Luzuriaga, K., Bell, J., Simmonds, P., Ball, J., Clapham, P. R. (2006). Non-macrophage-tropic human immunodeficiency virus type 1 r5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.. J. Virol. 80: 6324-6332 [Abstract] [Full Text]  
• Huerta, L., Gomez-Icazbalceta, G., Soto-Ramirez, L., Viveros-Rogel, M., Rodriguez, R., Fuentes, L., Lamoyi, E., Larralde, C. (2005). Human immunodeficiency virus 1 (HIV-1) envelope-dependent cell-cell fusion modulation by HIV-positive sera is related to disease progression. J. Gen. Virol. 86: 1961-1966 [Abstract] [Full Text]  
• Walter, B. L., Wehrly, K., Swanstrom, R., Platt, E., Kabat, D., Chesebro, B. (2005). Role of Low CD4 Levels in the Influence of Human Immunodeficiency Virus Type 1 Envelope V1 and V2 Regions on Entry and Spread in Macrophages. J. Virol. 79: 4828-4837 [Abstract] [Full Text]  
• Choudhary, S. K., Choudhary, N. R., Kimbrell, K. C., Colasanti, J., Ziogas, A., Kwa, D., Schuitemaker, H., Camerini, D. (2005). R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces Cytokine and CCR5 Expression. J. Virol. 79: 458-471 [Abstract] [Full Text]  
• Emori, Y., Ikeda, T., Ohashi, T., Masuda, T., Kurimoto, T., Takei, M., Kannagi, M. (2004). Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages. J. Gen. Virol. 85: 2603-2613 [Abstract] [Full Text]  
• Fulcher, J. A., Hwangbo, Y., Zioni, R., Nickle, D., Lin, X., Heath, L., Mullins, J. I., Corey, L., Zhu, T. (2004). Compartmentalization of Human Immunodeficiency Virus Type 1 between Blood Monocytes and CD4+ T Cells during Infection. J. Virol. 78: 7883-7893 [Abstract] [Full Text]  
• Gross, E., Amella, C. A., Pompucci, L., Franchin, G., Sherry, B., Schmidtmayerova, H. (2003). Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection. J. Leukoc. Biol. 74: 781-790 [Abstract] [Full Text]  
• Hsu, M., Harouse, J. M., Gettie, A., Buckner, C., Blanchard, J., Cheng-Mayer, C. (2002). Increased Mucosal Transmission but Not Enhanced Pathogenicity of the CCR5-Tropic, Simian AIDS-Inducing Simian/Human Immunodeficiency Virus SHIVSF162P3 Maps to Envelope gp120. J. Virol. 77: 989-998 [Abstract] [Full Text]  
• Patel, P. G., Yu Kimata, M. T., Biggins, J. E., Wilson, J. M., Kimata, J. T. (2002). Highly Pathogenic Simian Immunodeficiency Virus mne Variants That Emerge during the Course of Infection Evolve Enhanced Infectivity and the Ability To Downregulate CD4 but Not Class I Major Histocompatibility Complex Antigens. J. Virol. 76: 6425-6434 [Abstract] [Full Text]  
• Zheng, N. N., Vella, C., Easterbrook, P. J., Daniels, R. S. (2002). Selection following isolation of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and herpesvirus saimiri-transformed T cells is comparable. J. Gen. Virol. 83: 1343-1352 [Abstract] [Full Text]  
• Hoffman, N. G., Seillier-Moiseiwitsch, F., Ahn, J., Walker, J. M., Swanstrom, R. (2002). Variability in the Human Immunodeficiency Virus Type 1 gp120 Env Protein Linked to Phenotype-Associated Changes in the V3 Loop. J. Virol. 76: 3852-3864 [Abstract] [Full Text]  
• Suzuki, J.-i., Miyano-Kurosaki, N., Kuwasaki, T., Takeuchi, H., Kawai, G., Takaku, H. (2002). Inhibition of Human Immunodeficiency Virus Type 1 Activity In Vitro by a New Self-Stabilized Oligonucleotide with Guanosine-Thymidine Quadruplex Motifs. J. Virol. 76: 3015-3022 [Abstract] [Full Text]  
• Tanaka, R., Yoshida, A., Murakami, T., Baba, E., Lichtenfeld, J., Omori, T., Kimura, T., Tsurutani, N., Fujii, N., Wang, Z.-X., Peiper, S. C., Yamamoto, N., Tanaka, Y. (2001). Unique Monoclonal Antibody Recognizing the Third Extracellular Loop of CXCR4 Induces Lymphocyte Agglutination and Enhances Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation and Productive Infection. J. Virol. 75: 11534-11543 [Abstract] [Full Text]  
• Kim, S. S., You, X. J., Harmon, M.-E., Overbaugh, J., Fan, H. (2001). Use of Helper-Free Replication-Defective Simian Immunodeficiency Virus-Based Vectors To Study Macrophage and T Tropism: Evidence for Distinct Levels of Restriction in Primary Macrophages and a T-Cell Line. J. Virol. 75: 2288-2300 [Abstract] [Full Text]  
• Dejucq, N., Simmons, G., Clapham, P. R. (2000). T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism. J. Gen. Virol. 81: 2899-2904 [Abstract] [Full Text]  
• Beaumont, T., Broersen, S., van Nuenen, A., Huisman, H. G., de Roda Husman, A.-M., Heeney, J. L., Schuitemaker, H. (2000). Increased Neutralization Sensitivity and Reduced Replicative Capacity of Human Immunodeficiency Virus Type 1 after Short-Term In Vivo or In Vitro Passage through Chimpanzees. J. Virol. 74: 7699-7707 [Abstract] [Full Text]  
• Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., Henson, G. W. (2000). Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers. Antimicrob. Agents Chemother. 44: 1667-1673 [Abstract] [Full Text]  
• Tsurutani, N., Kubo, M., Maeda, Y., Ohashi, T., Yamamoto, N., Kannagi, M., Masuda, T. (2000). Identification of Critical Amino Acid Residues in Human Immunodeficiency Virus Type 1 IN Required for Efficient Proviral DNA Formation at Steps prior to Integration in Dividing and Nondividing Cells. J. Virol. 74: 4795-4806 [Abstract] [Full Text]  
• Blaak, H., van't Wout, A. B., Brouwer, M., Hooibrink, B., Hovenkamp, E., Schuitemaker, H. (2000). In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline. Proc. Natl. Acad. Sci. USA 97: 1269-1274 [Abstract] [Full Text]  
• Berkowitz, R. D., van 't Wout, A. B., Kootstra, N. A., Moreno, M. E., Linquist-Stepps, V. D., Bare, C., Stoddart, C. A., Schuitemaker, H., McCune, J. M. (1999). R5 Strains of Human Immunodeficiency Virus Type 1 from Rapid Progressors Lacking X4 Strains Do Not Possess X4-Type Pathogenicity in Human Thymus. J. Virol. 73: 7817-7822 [Abstract] [Full Text]  
• Kato, K., Sato, H., Takebe, Y. (1999). Role of Naturally Occurring Basic Amino Acid Substitutions in the Human Immunodeficiency Virus Type 1 Subtype E Envelope V3 Loop on Viral Coreceptor Usage and Cell Tropism. J. Virol. 73: 5520-5526 [Abstract] [Full Text]  
• Dean, G. A., Himathongkham, S., Sparger, E. E. (1999). Differential Cell Tropism of Feline Immunodeficiency Virus Molecular Clones In Vivo. J. Virol. 73: 2596-2603 [Abstract] [Full Text]  
• Kimata, J. T., Gosink, J. J., KewalRamani, V. N., Rudensey, L. M., Littman, D. R., Overbaugh, J. (1999). Coreceptor Specificity of Temporal Variants of Simian Immunodeficiency Virus Mne. J. Virol. 73: 1655-1660 [Abstract] [Full Text]  
• Zybarth, G., Reiling, N., Schmidtmayerova, H., Sherry, B., Bukrinsky, M. (1999). Activation-Induced Resistance of Human Macrophages to HIV-1 Infection In Vitro. J. Immunol. 162: 400-406 [Abstract] [Full Text]  
• Berkowitz, R. D., Alexander, S., Bare, C., Linquist-Stepps, V., Bogan, M., Moreno, M. E., Gibson, L., Wieder, E. D., Kosek, J., Stoddart, C. A., McCune, J. M. (1998). CCR5- and CXCR4-Utilizing Strains of Human Immunodeficiency Virus Type 1 Exhibit Differential Tropism and Pathogenesis In Vivo. J. Virol. 72: 10108-10117 [Abstract] [Full Text]  
• Grovit-Ferbas, K., Ferbas, J., Gudeman, V., Sadeghi, S., Goetz, M. B., Giorgi, J. V., Chen, I. S. Y., O'Brien, W. A. (1998). Potential Contributions of Viral Envelope and Host Genetic Factors in a Human Immunodeficiency Virus Type 1-Infected Long-Term Survivor. J. Virol. 72: 8650-8658 [Abstract] [Full Text]  
• Zhang, L., He, T., Huang, Y., Chen, Z., Guo, Y., Wu, S., Kunstman, K. J., Brown, R. C., Phair, J. P., Neumann, A. U., Ho, D. D., Wolinsky, S. M. (1998). Chemokine Coreceptor Usage by Diverse Primary Isolates of Human Immunodeficiency Virus Type 1. J. Virol. 72: 9307-9312 [Abstract] [Full Text]  
• Radaelli, A., Kraus, G., Schmidt, A., Badel, P., McClure, J., Hu, S.-L., Morton, W., De Giuli Morghen, C., Wong-Staal, F., Looney, D. (1998). Genetic Variation in a Human Immunodeficiency Virus Type 2 Live-Virus Macaca nemestrina Vaccine Model. J. Virol. 72: 7871-7884 [Abstract] [Full Text]  
• Schmidtmayerova, H., Alfano, M., Nuovo, G., Bukrinsky, M. (1998). Human Immunodeficiency Virus Type 1 T-Lymphotropic Strains Enter Macrophages via a CD4- and CXCR4-Mediated Pathway: Replication Is Restricted at a Postentry Level. J. Virol. 72: 4633-4642 [Abstract] [Full Text]  
• Zhang, L., He, T., Talal, A., Wang, G., Frankel, S. S., Ho, D. D. (1998). In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 72: 5035-5045 [Abstract] [Full Text]  
• van 't Wout, A. B., Blaak, H., Ran, L. J., Brouwer, M., Kuiken, C., Schuitemaker, H. (1998). Evolution of Syncytium-Inducing and Non-Syncytium-Inducing Biological Virus Clones in Relation to Replication Kinetics during the Course of Human Immunodeficiency Virus Type 1 Infection. J. Virol. 72: 5099-5107 [Abstract] [Full Text]  
• Reece, J. C., Handley, A. J., Anstee, E. J., Morrison, W. A., Crowe, S. M., Cameron, P. U. (1998). HIV-1 Selection by Epidermal Dendritic Cells during Transmission across Human Skin. J. Exp. Med. 187: 1623-1631 [Abstract] [Full Text]  
• Moriuchi, H., Moriuchi, M., Fauci, A. S. (1998). Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)-infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I-uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1. J. Exp. Med. 187: 1689-1697 [Abstract] [Full Text]  
• Moriuchi, H., Moriuchi, M., Fauci, A. S. (1998). Differentiation of Promonocytic U937 Subclones into Macrophagelike Phenotypes Regulates a Cellular Factor(s) Which Modulates Fusion/Entry of Macrophagetropic Human Immunodeficiency Virus Type 1. J. Virol. 72: 3394-3400 [Abstract] [Full Text]  
• Trkola, A., Ketas, T., KewalRamani, V. N., Endorf, F., Binley, J. M., Katinger, H., Robinson, J., Littman, D. R., Moore, J. P. (1998). Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage. J. Virol. 72: 1876-1885 [Abstract] [Full Text]  
• Picchio, G. R., Gulizia, R. J., Wehrly, K., Chesebro, B., Mosier, D. E. (1998). The Cell Tropism of Human Immunodeficiency Virus Type 1 Determines the Kinetics of Plasma Viremia in SCID Mice Reconstituted with Human Peripheral Blood Leukocytes. J. Virol. 72: 2002-2009 [Abstract] [Full Text]  
• Connor, R. I., Korber, B. T. M., Graham, B. S., Hahn, B. H., Ho, D. D., Walker, B. D., Neumann, A. U., Vermund, S. H., Mestecky, J., Jackson, S., Fenamore, E., Cao, Y., Gao, F., Kalams, S., Kunstman, K. J., McDonald, D., McWilliams, N., Trkola, A., Moore, J. P., Wolinsky, S. M. (1998). Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines. J. Virol. 72: 1552-1576 [Abstract] [Full Text]  
• Kimata, J. T., Mozaffarian, A., Overbaugh, J. (1998). A Lymph Node-Derived Cytopathic Simian Immunodeficiency Virus Mne Variant Replicates in Nonstimulated Peripheral Blood Mononuclear Cells. J. Virol. 72: 245-256 [Abstract] [Full Text]  
• Hori, T., Sakaida, H., Sato, A., Nakajima, T., Shida, H., Yoshie, O., Uchiyama, T. (1998). Detection and Delineation of CXCR-4 (Fusin) as an Entry and Fusion Cofactor for T Cell-Tropic HIV-1 by Three Different Monoclonal Antibodies. J. Immunol. 160: 180-188 [Abstract] [Full Text]  
• Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M. W., Hemophilia Growth and Development Study (HGDS), , Study, M. A. C. S. M. M. H. C. S. M. S. F. C. C. S. A., O'Brien, S. J. (1997). Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression. Science 277: 959-965 [Abstract] [Full Text]  
• Henderson, A. J., Calame, K. L. (1997). CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4+ T cells. Proc. Natl. Acad. Sci. USA 94: 8714-8719 [Abstract] [Full Text]  
• Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., Landau, N. R. (1997). Change in Coreceptor Use Correlates with Disease Progression in HIV-1-Infected Individuals. J. Exp. Med. 185: 621-628 [Abstract] [Full Text]  
• Chen, P., Flory, E., Avots, A., Jordan, B. W. M., Kirchhoff, F., Ludwig, S., Rapp, U. R. (2000). Transactivation of Naturally Occurring HIV-1 Long Terminal Repeats by the JNK Signaling Pathway. THE MOST FREQUENT NATURALLY OCCURRING LENGTH POLYMORPHISM SEQUENCE INTRODUCES A NOVEL BINDING SITE FOR AP-1 FACTORS. J. Biol. Chem. 275: 20382-20390 [Abstract] [Full Text]